Company Filing History:
Years Active: 2015
Title: Innovations by Steve Gross: Advancements in Biological Sample Analysis
Introduction
Steve Gross is an innovative inventor based in Ambler, PA (US), recognized for his contributions to the field of biological sample analysis. With a focus on enhancing the analysis of rare events in biological samples, his work has significant implications for medical diagnostics and research.
Latest Patents
Steve Gross holds a patent for a cutting-edge invention titled "High sensitivity multiparameter method for rare event analysis in a biological sample." This pioneering method involves staining a blood sample containing circulating tumor cells (CTCs) with fluorescent markers for image analysis. The process effectively identifies the presence and location of target cells or subcellular elements within a cartridge.
The invention further details a method where the sample is re-analyzed after processing, including photobleaching. This allows for additional analyses using biomarkers conjugated to various fluorochromes while maintaining the initial imaging criteria. This innovative approach has numerous applications, including the interrogation of circulating epithelial cells, circulating endothelial cells, leukocytes, and other cellular components of interest.
Career Highlights
Steve Gross is currently employed at Janssen Diagnostics, a prominent company focused on developing diagnostic solutions. His work embodies a commitment to advance scientific understanding and improve patient outcomes through innovative diagnostic methods.
Collaborations
Throughout his career, Steve has collaborated with notable coworkers such as Mark Carle Connelly and Frank Coumans. These partnerships reflect a collaborative spirit in the scientific community, bringing together diverse expertise to push the boundaries of current technologies in the field.
Conclusion
Steve Gross's contributions to biological sample analysis demonstrate the transformative potential of innovation in healthcare. His patent on the high sensitivity multiparameter method sets the stage for future breakthroughs in the detection and analysis of cellular components, reinforcing the significance of his work in the scientific and medical community.